Product Recalls in New York

Product recalls affecting New York — including food, drugs, consumer products, medical devices, and vehicles distributed to New York. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,868 recalls have been distributed to New York in the last 12 months.

55,896 total recalls
2,868 in last 12 months

Showing 49414960 of 13,591 recalls

DrugNovember 15, 2019· Rising Pharmaceuticals, Inc.

Recalled Item: Timolol Maleate USP Recalled by Rising Pharmaceuticals, Inc. Due to...

The Issue: Labeling: Label mix-up: A case of Timolol Maleate Sterile Ophthalmic...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugNovember 15, 2019· Akorn, Inc.

Recalled Item: MYORISAN (isotretinoin capsules Recalled by Akorn, Inc. Due to Unit Dose...

The Issue: Unit Dose Mispackaging: Customer complaint that a carton labeled as Myorisan...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 15, 2019· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Clobetasol Propionate Foam Recalled by Glenmark Pharmaceuticals Inc., USA...

The Issue: Defective delivery system; product is not foaming or is coming out as liquid.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugNovember 15, 2019· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Clobetasol Propionate Foam (Emulsion Formulation) Recalled by Glenmark...

The Issue: Defective delivery system; product is not foaming or is coming out as liquid.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugNovember 15, 2019· Grato Holdings, Inc.

Recalled Item: Colostat Recalled by Grato Holdings, Inc. Due to Labeling mix-up -...

The Issue: Labeling mix-up - Indications on product label are incorrect.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugNovember 14, 2019· AVKARE Inc.

Recalled Item: AVKARE Ranitidine Tablets Recalled by AVKARE Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 14, 2019· AVKARE Inc.

Recalled Item: AVKARE Ranitidine Tablets Recalled by AVKARE Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 13, 2019· Precision Dose Inc.

Recalled Item: Ranitidine Oral Solution Recalled by Precision Dose Inc. Due to CGMP...

The Issue: CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 13, 2019· Natures Rx

Recalled Item: Silver Bullet Recalled by Natures Rx Due to Undeclared Active

The Issue: Marketed Without an Approved NDA/ANDA; Product contains undeclared active...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugNovember 12, 2019· QuVa Pharma, Inc.

Recalled Item: fentaNYL 1000 mcg/20 mL (50 mcg/mL) 20 mL in 20 mL Syringe Preservative Free...

The Issue: Presence of Particulate matter: manufacturer recalled fentanyl API due to...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 12, 2019· QuVa Pharma, Inc.

Recalled Item: fentaNYL 2000 mcg/100 mL (20 mcg/mL) in 0.9% Sodium Chloride Recalled by...

The Issue: Presence of Particulate matter: manufacturer recalled fentanyl API due to...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 12, 2019· QuVa Pharma, Inc.

Recalled Item: fentaNYL 2750 mcg/55 mL (50 mcg/mL) 55 mL Syringe Recalled by QuVa Pharma,...

The Issue: Presence of Particulate matter: manufacturer recalled fentanyl API due to...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 12, 2019· QuVa Pharma, Inc.

Recalled Item: fentaNYL 2500 mcg/50 mL (50 mcg/mL) 50 mL bag Recalled by QuVa Pharma, Inc....

The Issue: Presence of Particulate matter: manufacturer recalled fentanyl API due to...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 12, 2019· QuVa Pharma, Inc.

Recalled Item: fentaNYL 200 mcg/100 mL (2 mcg/mL) ROPivacaine HCl 0.2% 200 Recalled by QuVa...

The Issue: Presence of Particulate matter: manufacturer recalled fentanyl API due to...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 12, 2019· QuVa Pharma, Inc.

Recalled Item: fentaNYL 1250 mcg/250 mL (5 mcg/mL) in 0.9% Sodium Chloride Recalled by QuVa...

The Issue: Presence of Particulate matter: manufacturer recalled fentanyl API due to...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 12, 2019· QuVa Pharma, Inc.

Recalled Item: fentaNYL 200 mcg/100 mL (2 mcg/mL) ROPivacaine HCl 0.2% 200 Recalled by QuVa...

The Issue: Presence of Particulate matter: manufacturer recalled fentanyl API due to...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 12, 2019· QuVa Pharma, Inc.

Recalled Item: fentaNYL 800 mcg/200 mL (4 mcg/mL) BUPivacaine HCl 0.1667% 333.4 Recalled by...

The Issue: Presence of Particulate matter: manufacturer recalled fentanyl API due to...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 12, 2019· QuVa Pharma, Inc.

Recalled Item: fentaNYL 550 mcg/55 mL (10 mcg/mL) in 0.9% Sodium Chloride Recalled by QuVa...

The Issue: Presence of Particulate matter: manufacturer recalled fentanyl API due to...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 12, 2019· QuVa Pharma, Inc.

Recalled Item: fentaNYL 400 mcg/200 mL (2 mcg/mL) ROPivacaine HCl 0.1% 200 Recalled by QuVa...

The Issue: Presence of Particulate matter: manufacturer recalled fentanyl API due to...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 12, 2019· QuVa Pharma, Inc.

Recalled Item: fentaNYL 200 mcg/100 mL (2 mcg/mL) BUPivacaine HCl 0.1% 100 Recalled by QuVa...

The Issue: Presence of Particulate matter: manufacturer recalled fentanyl API due to...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund